Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
10/2011
10/26/2011EP2380903A1 Differential in tumour gene products and use of same
10/26/2011EP2380593A1 Stabilizing labeled antibody using amino acids
10/26/2011EP2379730A1 Method for the preparation of diols
10/26/2011EP2379725A1 Method for increasing the saccharose yield in agricultural production of sugar beets and sugar cane
10/26/2011EP2379717A1 Process for production of an enzyme product
10/26/2011EP2379716A1 Polypeptides having alpha-mannosidase activity and polynucleotides encoding same
10/26/2011EP2379715A2 Polypeptide fragments comprising endonuclease activity and their use
10/26/2011EP2379714A1 Improved biocatalysts for manufacturing duloxetine alcohol
10/26/2011EP2379713A2 Recombinant halohydrin dehalogenase polypeptides
10/26/2011EP2379712A1 Methods for increasing hydrolysis of cellulosic material in the presence of cellobiose dehydrogenase
10/26/2011EP2379708A1 Synthesis of fucosylated compounds
10/26/2011EP2379098A1 Compositions and methods to prevent cancer with cupredoxins
10/26/2011EP2378897A1 Stabilization of asparaginase
10/26/2011EP2167675B1 Method for enzymatic cleavage of polysaccharides derived from algae
10/26/2011EP2046951B1 Protease screening methods and proteases identified thererby
10/26/2011EP1920053B1 Subtilases
10/26/2011EP1911839B1 Peptide-forming enzyme gene, peptide-forming enzyme, and dipeptide producing method
10/26/2011EP1831362B1 Acid fungal proteases
10/26/2011EP1702063B1 Modulation of enzyme activity by changing reciprocal stereo-geometric positions of two catalytic centers in an enzyme
10/26/2011EP1692158B1 Vegf binding and supported peptides for treating skin diseases
10/26/2011EP1668135B1 A non-denaturing process to purify recombinant proteins from plants
10/26/2011EP1520030B1 Microorganisms and processes for enhanced production of pantothenate
10/26/2011EP1484407B1 Method of controlling ethanol production and mass production of lactic acid and transformant therefor
10/26/2011EP1352055B1 Map kinase integrin-binding domain
10/26/2011EP1206551B2 Enzymatic synthesis of deoxyribonucleosides
10/26/2011EP0956359B1 High fidelity detection of nucleic acid differences by ligase detection reaction
10/26/2011CN202017025U Liquid micro-filtration, purification and separation device for biological enzyme hydrolyzed by yeasts
10/26/2011CN1922313B Acid alpha-glucosidase and fragments thereof
10/26/2011CN1826410B Polypeptide having an improved cytosine deaminase activity
10/26/2011CN102227500A Porphobilinogen deaminase gene therapy
10/26/2011CN102227499A Cellulolytic polypeptides and their use in micro-organisms for production of solvents and fuels
10/26/2011CN102227498A Cellulase cel5h related reagents and their use in microorganisms
10/26/2011CN102226209A Method for catalyzing and synthesizing vitamin E oleate by using lipase displayed on yeast
10/26/2011CN102226173A Stabilized enzyme preparation and preparation method and application thereof
10/26/2011CN102226172A Method for purifying protein of enzyme aggregate based on self-aggregation short-peptide induction
10/26/2011CN102225964A Self-assembling peptide amphiphiles and related methods for growth factor delivery
10/26/2011CN102225197A Application and extraction method of acrosin
10/26/2011CN101724637B Nucleotide sequence of delta 9 extending enzyme of chromulina, such as ball and the like, and application thereof
10/26/2011CN101525598B Method for purifying human urinary trypsin inhibitor
10/26/2011CN101250539B Method for preparing recombinant heat-proof beta-glucuronic acid enzyme
10/26/2011CN101228271B Method for bacillus coli to high effectively excrine representing lysostaphin
10/26/2011CN101063112B Nucleoside diphosphokinase A oxidation-reduction isomer
10/26/2011CN101007840B Method for keeping activity of active protein under normal temperature
10/25/2011US8044261 Glyphosate-N-acetyltransferase (GAT) genes
10/25/2011US8044193 Short interfering RNAs targeted to T-LAK cell-originated protein kinase (TOPK) polynucleotide
10/25/2011US8043855 vector contains an adenoviral genome from which the open reading frames E1 and/or E3 have been deleted, but retains enough sequence to make it able to replicate in vitro; also contains a DNA sequence regulated by promoters that encode for fibrosis treatment proteins
10/25/2011US8043844 Mixture obtained from penicillium funiculosum
10/25/2011US8043843 Metabolically engineered lactic acid bacteria and their use
10/25/2011US8043841 Nucleic acid molecules encoding alanine 2,3-aminomutases
10/25/2011US8043839 Xylanases, nucleic acids encoding them and methods for making and using them
10/25/2011US8043837 Aldolases, nucleic acids encoding them and methods for making and using them
10/25/2011US8043831 Therapeutic agents comprising pro-apoptotic proteins
10/25/2011US8043827 Single molecule-format real-time bioluminescence imaging probe
10/25/2011US8043818 Proteolytic enzyme for use as tool in identifying modulators for prevention and treatment of cell proliferative and immune disorders
10/25/2011US8043816 Compositions and methods for temperature-dependent nucleic acid synthesis
10/25/2011US8043638 Mutant ILV5 gene and use thereof
10/25/2011US8043629 Bioabsorbable synthetic nonwoven fabric holding thrombin
10/25/2011CA2415923C Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers
10/25/2011CA2409007C Novel laccase enzyme and the gene encoding the enzyme
10/25/2011CA2366277C Grb7 family proteins and the insulin receptor for screening new medications
10/25/2011CA2198222C Nucleotide sequences of canola and soybean palmitoyl-acp thioesterase genes and their use in the regulation of fatty acid content of the oils of soybean and canola plants
10/22/2011CA2700466A1 Modification of intrinsically disordered sequences for the preparation of vaccines
10/20/2011WO2011130533A1 Engineered plant cysteine proteases and their uses
10/20/2011WO2011130509A1 Mutants of l-arabinitol 4-dehydrogenase from neurospora crassa
10/20/2011WO2011130380A2 Coenzyme q10 production using sporidiobolus johnsonii
10/20/2011WO2011130354A1 Fibronectin based scaffold domain proteins that bind pcsk9
10/20/2011WO2011130347A2 Methods for enhancing axonal regeneration
10/20/2011WO2011130273A2 Optimized oligonucleotides and methods of using same for the screening, detection, isolation, quantitation, monitoring and sequencing of prostate cancer associated viruses and host biomarkers
10/20/2011WO2011130222A2 Compositions and methods comprising variant proteases
10/20/2011WO2011130076A1 Automatic dishwashing detergent composition
10/20/2011WO2011129428A1 Cosmetic composition containing plum extract
10/20/2011WO2011129293A1 Method for producing 1,5-pentanediamine
10/20/2011WO2011128907A1 A RECOMBINANT PROCESS FOR THE PRODUCTION OF R-AROMATIC α HYDROXY KETONES
10/20/2011WO2011128712A1 Biofuel production
10/20/2011WO2011128444A2 Capping-prone rna polymerase enzymes and their applications
10/20/2011WO2011127820A1 Processes for producing fermentation products
10/20/2011WO2011127802A1 Polypeptides having glucoamylase activity and polynucleotides encoding same
10/20/2011WO2011127589A1 Genes and proteins for aromatic polyketide synthesis
10/20/2011WO2011106696A3 Compositions and methods for the production of l-homoalanine
10/20/2011WO2011101339A3 Fermentation broth and filtration filter cake and uses thereof
10/20/2011WO2011084882A3 Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
10/20/2011WO2011084523A3 Ulk1 compositions, inhibitors, screening and methods of use
10/20/2011WO2011066372A3 Citrullination of human peptidylarginine deiminase 4 (pad-4) regulates its function and immunogenicity
10/20/2011WO2007033277A3 Polysaccharide sweetener compounds, process for manufacture, and method of selecting components for polysaccharide sweetener compounds based on user specific sweetener applications
10/20/2011US20110258714 Phytase variants
10/20/2011US20110257386 Isolation of nucleic acid
10/20/2011US20110257251 Telomerase inhibitors and methods of use thereof
10/20/2011US20110257250 Treating Insulin Secreting Cells
10/20/2011US20110257211 Small-Molecule Choline Kinase Inhibitors as Anti-Cancer Therapeutics
10/20/2011US20110257203 Inhibitors of bruton's tyrosine kinase
10/20/2011US20110257184 Shp-2 phosphatase inhibitor
10/20/2011US20110257165 Bicyclic pyrazoles as protein kinase inhibitors
10/20/2011US20110257155 Compounds and compositions as protein kinase inhibitors
10/20/2011US20110257153 Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase
10/20/2011US20110257130 Compositions and Methods for Treatment of Renin-Angiotensin Aldosterone System (RAAS)- Related Disorders
10/20/2011US20110257100 Inhibitors of Protein Tyrosine Kinase Activity
10/20/2011US20110257028 Method for selectively binding a substrate to sorbents by way of at least bivalent bonds
10/20/2011US20110257027 Gamma-secretase substrate and methods of use
10/20/2011US20110256610 Compositions And Methods Comprising Variant Microbial Proteases
10/20/2011US20110256609 Compositions And Methods Comprising Variant Microbial Proteases